Log In
Print this Print this

MRB-8001, MRLS-8001

  Manage Alerts
Collapse Summary General Information
Company Mirabilis Therapeutics B.V.
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHeart failure
Indication DetailsTreat heart failure with preserved ejection fraction
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today